Sign In

Lindsay Hoover

Investor, Entrepreneur, Diplomat

Lindsay Hoover is a Co-Founder and Managing Partner of JLS Fund, a venture capital firm focused on investing in psychedelic and plant-based medicine technologies.12 Here are some key details about her background and work:

Professional Experience

Lindsay Hoover has over 20 years of experience in finance, including investment banking, strategic advisory, and consulting.3 She co-founded JLS Fund in 2019 to invest in the emerging psychedelics industry.4

JLS Fund Focus

JLS Fund invests in:

  • Drug development and delivery technologies
  • Supporting and enhancing software and technologies
  • Related consumer products and services

The fund focuses on the intersection of science, technology, and neurology, leveraging the potential of plant-based and psychedelic medicines to address mental health and wellness.12

Industry Involvement

Lindsay Hoover is actively involved in the psychedelics industry:

  • She frequently speaks at conferences and events related to psychedelics and mental health investments.23
  • Hoover has moderated panels on topics like "Mental & Behavioral Health" and "Consolidation in the Psychedelics Industry".2
  • She contributes to discussions on differentiating investment opportunities between private and public companies in the psychedelics space.2

Recent Activity

In October 2022, Lindsay Hoover shared news about a JLS Fund I portfolio company, Gilgamesh, securing a "$2B next-gen neuro deal" with a pharmaceutical company.5

Lindsay Hoover's work with JLS Fund positions her as a key figure in the emerging psychedelics investment landscape, focusing on the potential of these technologies to address mental health challenges and enhance wellness.

Highlights

May 14 · linkedin

We're thrilled to share the latest regarding our JLS Fund I portfolio company Gilgamesh - inking a "$2B next-gen neuro deal" with pharmaceutical giant AbbVie. We've supported this superlative team since the Company's inception and have participated in every financing to date. JLS Fund II is still accepting subscriptions as we continue to support innovators who execute - bringing cutting-edge therapeutics and enabling technologies to the overwhelming demand for effective brain health solutions.

https://lnkd.in/gk7-SZaS

Oct 17 · linkedin

Join me at #SOCAP23, October 23 to 25, in San Francisco! During this multi-day, action-oriented event, investors, entrepreneurs, and social impact leaders will convene to accelerate progress against the world’s toughest challenges through market-based solutions. I’m presenting on Impact Investment in Psychedelics: exploring uncharted waters in mental health impact - with Josh Hardman of Psychedelic Alpha, Henry Elkus of Helena, Miriam Volat of Riverstyx Foundation and Liana Gillooly of MAPS. Use code s23_speaker to save $250 on your ticket and join the conversation with us! https://lnkd.in/gce6GfTh  See you there!

Related Questions

What inspired Lindsay Hoover to co-found JLS Fund?
How has Lindsay Hoover's background in finance influenced her approach to investing in psychedelics?
What are some notable investments made by JLS Fund under Lindsay Hoover's leadership?
How does Lindsay Hoover see the future of psychedelic medicine evolving?
What are the key challenges Lindsay Hoover faces in the PsyTech venture fund?
Lindsay Hoover
Lindsay Hoover, photo 1
Lindsay Hoover, photo 2
Add to my network

Location

Carmel Valley, California, United States